BiotechTube

ABT-143 + simvastatin

Phase 3Completed
0 watching 0 views this week📈 Rising
77
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Dyslipidemia, Hypercholesterolemia, Hypertriglyceridemia

Conditions

Dyslipidemia, Hypercholesterolemia, Hypertriglyceridemia

Trial Timeline

Nov 1, 2008 → Jun 1, 2009

NCT ID
NCT00812955

About ABT-143 + simvastatin

ABT-143 + simvastatin is a phase 3 stage product being developed by AstraZeneca for Dyslipidemia, Hypercholesterolemia, Hypertriglyceridemia. The current trial status is completed. This product is registered under clinical trial identifier NCT00812955. Target conditions include Dyslipidemia, Hypercholesterolemia, Hypertriglyceridemia.

Hype Score Breakdown

Clinical
27
Activity
18
Company
10
Novelty
9
Community
10

Clinical Trials (1)

NCT IDPhaseStatus
NCT00812955Phase 3Completed

Competing Products

20 competing products in Dyslipidemia, Hypercholesterolemia, Hypertriglyceridemia

See all competitors
ProductCompanyStageHype Score
LY3202328 + Placebo + Atorvastatin + SimvastatinEli LillyPhase 1
33
Pitavastatin + PravastatinEli LillyApproved
85
Rosuampin 10/5mg + Rosuampin 20/5mg + Amlodipine/Atorvastatin 5/20mgYuhanApproved
85
YH14755 + Metformin + RosuvastatinYuhanPhase 3
77
YHR1705 + YHR1706 + YHR1705+YHR1706YuhanPhase 1
33
Moderate-intensity statin monotherapy + Ezetimibe or ezetimibe-statin combination therapyYuhanPre-clinical
23
Crestor 20mg(Rosuvastatin 20mg), Micardis 80mg(Telmisartan 80mg) , FDCYuhanPhase 1
33
MevalotinDaiichi SankyoPre-clinical
23
PravastatinDaiichi SankyoPre-clinical
23
LY3475766 - IV + LY3475766 - SC + Placebo - IV + Placebo - SCEli LillyPhase 1
33
LY3885125 + PlaceboEli LillyPhase 1
33
LY3561774 + PlaceboEli LillyPhase 1
33
LY2484595 + Atorvastatin + Simvastatin + Rosuvastatin + Placebo for LY2484595 + Placebo for StatinsEli LillyPhase 2
52
LY3561774 + PlaceboEli LillyPhase 2
52
LY2484595 + Placebo + AtorvastatinEli LillyPhase 2
52
EvacetrapibEli LillyPhase 1
33
PPAR alpha + placeboEli LillyPhase 2
52
AZD0780 + Ezetimibe + Rosuvastatin + Bempedoic Acid + PlaceboAstraZenecaPhase 1
33
ABT-335 + RosuvastatinAstraZenecaPhase 1
33
AZD6615 + PlaceboAstraZenecaPhase 1
33

Other Products from AstraZeneca

QuetiapineApproved
85
Dapagliflozin 5 mg + Placebo tabletApproved
85
QuetiapineApproved
85
Ticagrelor + ClopidogrelApproved
85
DurvalumabApproved
85